Pfizer-BioNTech COVID-19 vaccine-associated tinnitus and treatment with transcranial magnetic stimulation

QJM. 2022 Sep 22;115(9):623-624. doi: 10.1093/qjmed/hcac124.
No abstract available

MeSH terms

  • BNT162 Vaccine* / adverse effects
  • COVID-19* / prevention & control
  • Humans
  • Tinnitus* / etiology
  • Tinnitus* / therapy
  • Transcranial Magnetic Stimulation / adverse effects

Substances

  • BNT162 Vaccine